Advertisement

Local Excision: Indications and Techniques

  • Deborah S. Keller
  • Elizabeth R. Raskin
Chapter

Abstract

The treatment for rectal cancer continues to evolve. Advances in surgical technique and chemoradiation are decreasing local recurrence and downstaging the disease enough to impact treatment plans. Surgical excision of the primary tumor remains essential for eradication of disease. Local excision is increasing in popularity for its low morbidity and excellent functional results. However, its use is limited by the inability to assess regional lymph nodes and uncertainty of oncologic outcome [1]. Questions remain on who is a candidate, if there is a need for adjuvant treatment in addition to local excision, and how to handle failures of local excision. Careful preoperative staging, patient selection, and multidisciplinary team and patient input is vital for using local excision as curative therapy in appropriate patients.

References

  1. 1.
    Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236:522–9. discussion 529PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    American Cancer Society. Cancer facts and figures 2018. Atlanta: American Cancer Society; 2018.Google Scholar
  3. 3.
    Siegel RL, Miller DK, Fedewa SA, Ahnen DJ, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–93.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327–34.PubMedCrossRefGoogle Scholar
  7. 7.
    Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312:1465–72.CrossRefGoogle Scholar
  8. 8.
    Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324:709–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Heald RJ. The ‘holy plane’ of rectal surgery. J R Soc Med. 1988;81:503–8.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11:835–44.PubMedCrossRefGoogle Scholar
  14. 14.
    Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a “wait and see” policy justified? Dis Colon Rectum. 2008;51:10–9. discussion 19.PubMedCrossRefGoogle Scholar
  15. 15.
    Heafner TA, Glasgow SC. A critical review of the role of local excision in the treatment of early (T1 and T2) rectal tumors. J Gastrointest Oncol. 2014;5:345–52.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Allaix ME, Fichera A. Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery. Ann Surg Oncol. 2013;20:2921–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242:472–7. discussion 477.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Blumberg D, Paty PB, Guillem JG, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum. 1999;42:881–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 2005;48:1380–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum. 2005;48:711–9. discussion 719.CrossRefPubMedGoogle Scholar
  21. 21.
    Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg. 1999;230:49–54.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99:918–28.PubMedCrossRefGoogle Scholar
  23. 23.
    Jessup JM, Stewart AK, Menck HR. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985–95. Cancer. 1998;83:2408–18.PubMedCrossRefGoogle Scholar
  24. 24.
    Stitzenberg KB, Sanoff HK, Penn DC, Meyers MO, Tepper JE. Practice patterns and long-term survival for early-stage rectal cancer. J Clin Oncol. 2013;31:4276–82.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Rectal Cancer, Version 3.2017. https://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf. Accessed June 2017.
  26. 26.
    Ha SS, Choi HJ, Park KJ, et al. Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma. Cancer Res Treat. 2005;37:177–82.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Glasgow SC, Bleier JI, Burgart LJ, Finne CO, Lowry AC. Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases. J Gastrointest Surg. 2012;16:1019–28.PubMedCrossRefGoogle Scholar
  28. 28.
    Salinas HM, Dursun A, Klos CL, et al. Determining the need for radical surgery in patients with T1 rectal cancer. Arch Surg. 2011;146:540–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Tytherleigh MG, Warren BF, Mortensen NJ. Management of early rectal cancer. Br J Surg. 2008;95:409–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 1985;89:328–36.PubMedCrossRefGoogle Scholar
  31. 31.
    Kyzer S, Begin LR, Gordon PH, Mitmaker B. The care of patients with colorectal polyps that contain invasive adenocarcinoma. Endoscopic polypectomy or colectomy? Cancer. 1992;70:2044–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Bujanda L, Cosme A, Gil I, Arenas-Mirave JI. Malignant colorectal polyps. World J Gastroenterol. 2010;16:3103–11.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Kikuchi R, Takano M, Takagi K, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38:1286–95.PubMedCrossRefGoogle Scholar
  34. 34.
    Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45:200–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Morino M, Allaix ME, Caldart M, Scozzari G, Arezzo A. Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm. Surg Endosc. 2011;25:3683–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Nivatvongs S. Surgical management of early colorectal cancer. World J Surg. 2000;24:1052–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Baxter NN, Garcia-Aguilar J. Organ preservation for rectal cancer. J Clin Oncol. 2007;25:1014–20.PubMedCrossRefGoogle Scholar
  38. 38.
    Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58:122–40.PubMedCrossRefGoogle Scholar
  39. 39.
    You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245:726–33.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Nash GM, Weiser MR, Guillem JG, et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009;52:577–82.PubMedCrossRefGoogle Scholar
  41. 41.
    Landmann RG, Wong WD, Hoepfl J, et al. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum. 2007;50:1520–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43:1064–71. discussion 1071.CrossRefPubMedGoogle Scholar
  43. 43.
    Balani A, Turoldo A, Braini A, Scaramucci M. Role of curative local excision in rectal cancer. Ann Ital Chir. 1999;70:713–20. discussion 720.PubMedGoogle Scholar
  44. 44.
    Atallah S, Keller D. Why the conventional parks transanal excision for early stage rectal cancer should be abandoned. Dis Colon Rectum. 2015;58:1211–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Color Dis. 2014;16:2–14.CrossRefGoogle Scholar
  46. 46.
    Garcia-Aguilar J, Holt A. Optimal management of small rectal cancers: TAE, TEM, or TME? Surg Oncol Clin N Am. 2010;19:743–60.PubMedCrossRefGoogle Scholar
  47. 47.
    Garcia-Aguilar J, Shi Q, Thomas CRJ, et al. A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012;19:384–91.PubMedCrossRefGoogle Scholar
  48. 48.
    Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688–96.PubMedCrossRefGoogle Scholar
  49. 49.
    Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711–7. discussion 717.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10:1319–28. discussion 1328.PubMedCrossRefGoogle Scholar
  51. 51.
    Lee NK, Kim DY, Kim SY, et al. Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. Cancer Res Treat. 2014;46:158–64.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Shaikh I, Askari A, Ourû S, Warusavitarne J, Athanasiou T, Faiz O. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Color Dis. 2015;30:19–29.CrossRefGoogle Scholar
  53. 53.
    Borstlap WA, Coeymans TJ, Tanis PJ, et al. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery. Br J Surg. 2016;103:1105–16.PubMedCrossRefGoogle Scholar
  54. 54.
    Borstlap WA, Tanis PJ, Koedam TW, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer. 2016;16:513.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16:1537–46.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    You YN, Roses RE, Chang GJ, et al. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012;55:1213–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Bikhchandani J, Ong GK, Dozois EJ, Mathis KL. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer. Dis Colon Rectum. 2015;58:283–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Althumairi AA, Gearhart SL. Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond. J Gastrointest Oncol. 2015;6:296–306.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Hompes R, Cunningham C. Extending the role of transanal endoscopic microsurgery (TEM) in rectal cancer. Color Dis. 2011;13(Suppl 7):32–6.CrossRefGoogle Scholar
  60. 60.
    Elmessiry MM, Van Koughnett JA, Maya A, et al. Local excision of T1 and T2 rectal cancer: proceed with caution. Color Dis. 2014;16:703–9.CrossRefGoogle Scholar
  61. 61.
    Hahnloser D, Wolff BG, Larson DW, Ping J, Nivatvongs S. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum. 2005;48:429–37.PubMedCrossRefGoogle Scholar
  62. 62.
    Yatsuoka T, Nishimura Y, Sakamoto H, Tanaka Y, Kurozumi M. Long-term outcome of local excision for lower rectal cancer. Gan To Kagaku Ryoho. 2012;39:2176–8.PubMedGoogle Scholar
  63. 63.
    Perez RO, Habr-Gama A, São Julião GP, et al. Transanal endoscopic microsurgery (TEM) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence. Ann Surg Oncol. 2016;23:1143–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Benson AB, Bekaii-Saab T, Chan E, et al. Rectal cancer. J Natl Compr Cancer Netw. 2012;10:1528–64.CrossRefGoogle Scholar
  65. 65.
    Casadesus D. Surgical resection of rectal adenoma: a rapid review. World J Gastroenterol. 2009;15:3851–4.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Demartines N, von Flue MO, Harder FH. Transanal endoscopic microsurgical excision of rectal tumors: indications and results. World J Surg. 2001;25:870–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Morino M, Allaix ME. Transanal endoscopic microsurgery: what indications in 2013? Gastroenterol Rep (Oxf). 2013;1:75–84.CrossRefGoogle Scholar
  68. 68.
    Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum. 1996;39:969–76.PubMedCrossRefGoogle Scholar
  69. 69.
    Langer C, Liersch T, Suss M, et al. Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Color Dis. 2003;18:222–9.Google Scholar
  70. 70.
    Moore JS, Cataldo PA, Osler T, Hyman NH. Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon Rectum. 2008;51:1026–30. discussion 1030.PubMedCrossRefGoogle Scholar
  71. 71.
    Allaix ME, Arezzo A, Giraudo G, Morino M. Transanal endoscopic microsurgery vs. laparoscopic total mesorectal excision for T2N0 rectal cancer. J Gastrointest Surg. 2012;16:2280–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Whitehouse PA, Tilney HS, Armitage JN, Simson JN. Transanal endoscopic microsurgery: risk factors for local recurrence of benign rectal adenomas. Color Dis. 2006;8:795–9.CrossRefGoogle Scholar
  73. 73.
    Whitehouse PA, Armitage JN, Tilney HS, Simson JN. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer. Color Dis. 2008;10:187–93.Google Scholar
  74. 74.
    Ganai S, Kanumuri P, Rao RS, Alexander AI. Local recurrence after transanal endoscopic microsurgery for rectal polyps and early cancers. Ann Surg Oncol. 2006;13:547–56.PubMedCrossRefGoogle Scholar
  75. 75.
    Bach SP, Hill J, Monson JR, et al. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009;96:280–90.PubMedCrossRefGoogle Scholar
  76. 76.
    Stipa F, Burza A, Lucandri G, et al. Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study. Surg Endosc. 2006;20:541–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Stipa F, Lucandri G, Ferri M, Casula G, Ziparo V. Local excision of rectal cancer with transanal endoscopic microsurgery (TEM). Anticancer Res. 2004;24:1167–72.PubMedGoogle Scholar
  78. 78.
    Suppiah A, Maslekar S, Alabi A, Hartley JE, Monson JR. Transanal endoscopic microsurgery in early rectal cancer: time for a trial? Color Dis. 2008;10:314–27. discussion 327.CrossRefGoogle Scholar
  79. 79.
    Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Albert MR, Atallah SB, deBeche-Adams TC, Izfar S, Larach SW. Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and outcomes in the first 50 patients. Dis Colon Rectum. 2013;56:301–7.PubMedCrossRefGoogle Scholar
  81. 81.
    Baik SH, Kang CM, Lee WJ, Kim NK, Sohn SK, Chi HS, Cho CH. Robotic total mesorectal excision for the treatment of rectal cancer. J Robot Surg. 2007;1:99–102.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Luca F, et al. Full robotic left colon and rectal cancer resection: technique and early outcome. Ann Surg Oncol. 2009;16:1274–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Park YM, Kim WS, Byeon HK, de Virgilio A, Lee SY, Kim SH. Clinical outcomes of transoral robotic surgery for head and neck tumors. Ann Otol Rhinol Laryngol. 2013;122:73–84.PubMedCrossRefGoogle Scholar
  84. 84.
    Atallah SB, Albert MR, deBeche-Adams TH, Larach SW. Robotic transanal minimally invasive surgery in a cadaveric model. Tech Coloproctol. 2011;15:461–4.PubMedCrossRefGoogle Scholar
  85. 85.
    Atallah SB, Parra-Davila E, deBeche-Adams TH, Albert MR, Larach SW. Excision of a rectal neoplasm using robotic transanal surgery (RTS): a description of the technique. Tech Coloproctol. 2012;16:389–92.PubMedCrossRefGoogle Scholar
  86. 86.
    Bardakcioglu O. Robotic transanal access surgery. Surg Endosc. 2013;27:1407–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Hompes R, Rauh SM, Ris F, Tuynman JB, Mortensen NJ. Robotic transanal minimally invasive surgery for local excision of rectal neoplasms. Br J Surg. 2014;101:578–81.PubMedCrossRefGoogle Scholar
  88. 88.
    Williams JG, Pullan RD, Hill J, Horgan PG, Salmo E, Buchanan GN, Rasheed S, McGee SG, Haboubi N. Association of Coloproctology of Great Britain and Ireland, Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis. 2013;15(Suppl 2):1–38.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Deborah S. Keller
    • 1
  • Elizabeth R. Raskin
    • 2
  1. 1.Division of Colon and Rectal SurgeryColumbia University Medical CenterNew YorkUSA
  2. 2.Department of SurgeryLoma Linda University HealthLoma LindaUSA

Personalised recommendations